December 7, 2022


Photo courtesy of Dr Ganatra graphic from Getty Images

The carbon footprint of care

Health care organizations' emissions are working against their efforts to improve health, and it's time for change, an expert says.

Brief Case | FREE
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

Cranial nerve III palsy

A patient with kidney disease and diabetes presented with diplopia and severe left-sided ptosis.

Coronavirus | FREE
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

Screening patients, visitors, staff at hospital entrances didn't catch much COVID-19

Of nearly 1 million individuals screened for COVID-19 symptoms or exposure at entrances of a U.S. academic medical center from March 17, 2020, to May 8, 2021, fewer than 0.1% had a failed screening. The estimated cost to identify one screening failure was $2,351.

Evidence supporting perioperative management of anticoagulants remains limited

A systematic review and meta-analysis of studies addressing perioperative management of antithrombotic therapy, developed for a clinical practice guideline by the American College of Chest Physicians, found that data were sparse overall.

Studies estimate risks of bleeding, death in patients with cancer and atrial fibrillation

One recent study compared the predictive value of the HAS-BLED, ATRIA, and ORBIT scores in patients with cancer and afib, while another looked at clot, bleeding, and mortality risk with warfarin versus a direct-acting oral anticoagulant in patients with both conditions.

Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes

A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).